NCT02170311View on ClinicalTrials.gov

Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

March 31, 2015

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Z-213

Trial Locations (1)

Unknown

Zeria Investigative Site, Tokyo

Sponsors
All Listed Sponsors
lead

Zeria Pharmaceutical

INDUSTRY